LarraƱaga-Vera, Ane
Toti, Kiran S.
Flatow, James S.
Haraczy, Alexandra J.
Warnick, Eugene
Rao, Harsha
Gao, Zhan-Guo
Sussman, Sarah M.
Mediero, Aranzazu
Leucht, Philipp
Jacobson, Kenneth A.
Cronstein, Bruce N.
Article History
Received: 1 August 2022
Accepted: 29 November 2022
First Online: 9 December 2022
Declarations
:
: All protocols followed internationally recognized guidelines and were approved by the NYU SoM Institutional Animal Care and Use Committee. Human bone marrow was obtained from surgical specimens (knee replacement) that would have otherwise been discarded. This use of deidentified tissue is exempt from Institutional Review Board approval.
: Dr. Ane Larranaga-Vera, Dr. Kiran Toti, Mr. James Flatow, Ms. Alexandra Haraczy, Mr. Eugene Warnick, Mr. Harsha Rao, Dr. Zhan-Guo Gao, Ms. Sarah Sussman, Dr. Philipp Leucht, and Dr. Kenneth Jacobson declare that they have no competing interests. Dr. Aranzazu Mediero and Dr. Bruce Cronstein have a patent on use of Adenosine A1 receptor antagonists and A2A receptor agonists for the promotion of bone regeneration pending. Dr. Cronstein is a co-founder of Regenosine, a startup formed to exploit the utility of adenosine receptor agonists for the treatment of osteoarthritis and other related diseases.